Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,640 | -14,909 | -19,161 | -25,005 | 2,373 |
| Depreciation Amortization | 838 | 313 | 98 | 338 | 150 |
| Accounts receivable | -372 | -632 | 118 | -2,024 | -1,678 |
| Accounts payable and accrued liabilities | 290 | -36 | N/A | -11 | 343 |
| Other Working Capital | -2,117 | -2,442 | -341 | -3,320 | -2,254 |
| Other Operating Activity | 8,217 | 18,785 | 20,432 | 32,370 | 2,829 |
| Operating Cash Flow | $2,216 | $1,079 | $1,146 | $2,348 | $1,763 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -356 | -266 | N/A | -500 | -339 |
| Net Acquisitions | -11,188 | -12,439 | N/A | N/A | N/A |
| Purchase Of Investment | -1,000 | N/A | N/A | -6,000 | -6,000 |
| Other Investing Activity | -453 | 0 | -156 | 0 | 0 |
| Investing Cash Flow | $-12,997 | $-12,705 | $-156 | $-6,500 | $-6,339 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -18 |
| Common Stock Issued | 1,394 | 600 | 184 | 20,508 | 20,000 |
| Dividend Paid | N/A | N/A | N/A | -436 | -306 |
| Other Financing Activity | -65 | -14 | -7 | 8,074 | 10,618 |
| Financing Cash Flow | $1,329 | $586 | $177 | $28,146 | $30,294 |
| Beginning Cash Position | 30,657 | 30,657 | 30,657 | 6,663 | 6,663 |
| End Cash Position | 21,205 | 19,617 | 31,824 | 30,657 | 32,381 |
| Net Cash Flow | $-9,452 | $-11,040 | $1,167 | $23,994 | $25,718 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,216 | 1,079 | 1,146 | 2,348 | 1,763 |
| Capital Expenditure | -356 | -266 | N/A | -500 | -339 |
| Free Cash Flow | 1,860 | 813 | 1,146 | 1,848 | 1,424 |